Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q2

6095.TEDINET S100TEBI
Period2023-10-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥7.9bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥14.5bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥7.1bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥836m2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥717m2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥831m2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥1.2bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥735m2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥550m2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥735m2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥199m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥618m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥380m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥213m2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥391m2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥14.9bnat 2024-03-31Cons.Assets
Total assets¥15.2bnat 2023-09-30Cons.Assets
Total assets¥14.5bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥6.2bnat 2024-03-31Cons.Liabilities
Total liabilities¥6.6bnat 2023-09-30Cons.Liabilities
Net assets / equity¥8.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.6bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.8bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥5.4bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥5.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥807m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥600m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥122m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥47m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.0bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.8bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥378m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥3.7bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥9.182023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.162024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.332022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.422022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.032023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥27.992022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥17.052022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio56.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio57.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥685m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥15,000
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥1.5bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2023-10-01 → 2024-03-31−¥131m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥419,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥153m
—segment totalrevenue2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥434,000
—segment totalsegment profit2023-10-01 → 2024-03-31¥1.5bn
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥657m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥243m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥240m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-03-31−¥40m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥300,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥94m
—segment totalrevenue2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥5m
—segment totalsegment profit2022-10-01 → 2023-03-31¥1.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 519
ItemContextValueUnit
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-434000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember6409286000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember233633000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember1207737000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember7850656000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-434000JPY
Net salesCurrentYTDDuration7850221000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember1498860000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember-130974000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember152899000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember1520786000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-684791000JPY
Operating incomeCurrentYTDDuration835994000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-05-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第20期第２四半期（自　2024年１月１日　至　2024年３月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)メドピア株式会社
Company name in english cover pageFilingDateInstantMedPeer, Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 CEO　　石見　陽
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都中央区築地一丁目13番１号
Telephone number address of registered headquarter cover pageFilingDateInstant03-4405-4905
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役 兼 執行役員 CFO　　平林　利夫
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区築地一丁目13番１号
Telephone number nearest place of contact cover pageFilingDateInstant03-4405-4905
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役 兼 執行役員 CFO　　平林　利夫
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE30650
Fund codeFilingDateInstant－
Security codeFilingDateInstant60950
Filer name in japaneseFilingDateInstant
Original text (Japanese)メドピア株式会社
Filer name in englishFilingDateInstantMedPeer, Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2023-10-01
Current period end dateFilingDateInstant2024-03-31
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2024-09-30
Previous fiscal year start dateFilingDateInstant2022-10-01
Comparative period end dateFilingDateInstant2023-03-31
Previous fiscal year end dateFilingDateInstant2023-09-30
Next fiscal year start dateFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass